BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Beijing QL Biopharmaceutical readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Beijing QL Biopharmaceutical's dr
 ugs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07230132-205@assetmemo.bio
DTSTAMP:20261121T005941Z
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261213
SUMMARY:ZT006: Phase 2 readout est. (NCT07230132)
DESCRIPTION:ZT006\, phase 2\, Obesity.\nStudy: Efficacy and Safety of ZT006
  in Overweight and Obese Participants\nEstimated primary completion: 12 De
 cember 2026. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/zt006#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT072301
 32
URL:https://assetmemo.bio/drug/zt006#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07230119-202@assetmemo.bio
DTSTAMP:20261121T005941Z
DTSTART;VALUE=DATE:20270529
DTEND;VALUE=DATE:20270530
SUMMARY:zovaglutide: Phase 3 readout est. (NCT07230119)
DESCRIPTION:zovaglutide\, phase 3\, Obesity.\nStudy: A Study of Zovaglutide
  in Subjects With Overweight or Obesity (HORIZON-1)\nEstimated primary com
 pletion: 29 May 2027. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /zovaglutide#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07230119
URL:https://assetmemo.bio/drug/zovaglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07812597-202@assetmemo.bio
DTSTAMP:20261121T005941Z
DTSTART;VALUE=DATE:20280113
DTEND;VALUE=DATE:20280114
SUMMARY:zovaglutide: Phase 2 readout est. (NCT07812597)
DESCRIPTION:zovaglutide\, phase 2\, Obesity.\nStudy: A Study Evaluating Saf
 ety and Tolerability of Switching From Semaglutide to Zovaglutide in Adult
 s With Obesity (HORIZON-SWITCH-SZ)\nEstimated primary completion: 13 Janua
 ry 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/zovaglutide#
 upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0781
 2597
URL:https://assetmemo.bio/drug/zovaglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
